Canada markets close in 3 hours 21 minutes

Eli Lilly and Company (LLY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
319.34+5.88 (+1.88%)
As of 12:39PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close313.46
Open312.65
Bid318.98 x 800
Ask319.15 x 1100
Day's Range311.26 - 319.79
52 Week Range196.68 - 319.79
Volume1,638,737
Avg. Volume2,979,815
Market Cap303.424B
Beta (5Y Monthly)0.40
PE Ratio (TTM)47.46
EPS (TTM)6.73
Earnings DateAug 04, 2022
Forward Dividend & Yield3.92 (1.28%)
Ex-Dividend DateMay 13, 2022
1y Target Est304.28
  • Motley Fool

    Is This Dividend Growth Stock a Buy?

    The pharma stock Eli Lilly (NYSE: LLY) has surged 13% higher year to date. Let's dive into Eli Lilly's fundamentals and valuation to find out. Eli Lilly reported $7.8 billion in revenue for the first quarter ended March 31, up 14.8% from the year-ago period.

  • Simply Wall St.

    What You Need To Know About Eli Lilly and Company's (NYSE:LLY) Investor Composition

    The big shareholder groups in Eli Lilly and Company ( NYSE:LLY ) have power over the company. Institutions will often...

  • Motley Fool

    Why This FDA Approval Is a Game Changer for Eli Lilly

    Eli Lilly (NYSE: LLY) is a top healthcare company that continually finds new ways to grow and create value for its investors. One of the company's recent diabetes treatments has obtained approval from the U.S. Food and Drug Administration (FDA). On May 13, Eli Lilly announced that the FDA had approved Mounjaro (tirzepatide) to treat people with type 2 diabetes.